Menu Display

Breadcrumb

Empowering Patients: Why Clear, Accurate Information About Cancer Matters to Me

Empowering patients and caregivers with clear, scientifically accurate medical information they can trust is integral to what we do. Andrew Perez-Viñas, a Medical Review Manager at Daiichi Sankyo, shares his commitment to ensuring medical materials are accurate and easy to understand—especially to those with limited health literacy or language barriers.  

 

Category Filter

Asset Publisher

Content with Our Story Patient Centricity .

Empowering Patients: Why Clear, Accurate Information About Cancer Matters to Me
Empowering Patients: Why Clear, Accurate Information About Cancer Matters to Me

Growing up in a Spanish-speaking home, I was the family translator—a role that became particularly challenging when my mother was diagnosed with breast cancer. My family relied on me…

Understanding Metastatic Breast Cancer: Meeting Patient Needs
Understanding Metastatic Breast Cancer: Meeting Patient Needs

Each patient journey is unique for those faced with a breast cancer diagnosis. At Daiichi Sankyo, we strive to deepen our understanding beyond the scientific aspects, distinguishing between the personal needs of patients with early-stage versus metastatic breast cancer.

Translating the Science of ADCs for Patients with Cancer 
Translating the Science of ADCs for Patients with Cancer 

Informed patients are empowered patients. Which is why helping people with cancer understand their disease, as well as how available treatment options might work for them, is a critical focus of our patient advocacy efforts.

Translating Science for Patients—The Craft of a Passionate Advocate
Translating Science for Patients—The Craft of a Passionate Advocate

For cancer patients, the science concerning their disease is sometimes outside of reach. As a patient-centric organization, we are on a mission to break down those barriers.

Biomarker Testing and the Power of Information
Biomarker Testing and the Power of Information

Cancer remains one of the most challenging diseases in the world today, but critical advances in science are transforming options for more personalized treatment.

The Critical Role of Biomarker Testing in Lung Cancer
The Critical Role of Biomarker Testing in Lung Cancer

Daiichi Sankyo supports “No One Missed” campaign to build awareness, empower patients and break down barriers to this essential step in cancer care.